In This Section

‘Bath Salts’: The Ever-Changing Landscape of Synthetic Cathinones

Tuesday April 24, 2018

9:30 am - 12:00 pm Eastern Time (ET)

Room 16B


Chair :

Michael Taffe
Scripps Research Institute

Stephen Kohut
Harvard Medical School

Sponsored by La Jolla Alcohol Research, Inc.

The use of novel cathinone analogs, popularly referred to as ‘bath salts,’ has emerged as a substance abuse problem in the US in recent years. These substances are produced and distributed by clandestine markets in an attempt to circumvent their status as illegal substances. New synthetic cathinones that differ slightly in chemical structure and pharmacology from previous analogs, continue to show up in confiscated samples at an alarming rate. Synthetic cathinones share many of the neurochemical effects of psychomotor stimulants such as methamphetamine, cocaine, or MDMA, but differ on a range of behavioral and physiological endpoints.


Richard Glennon - Virginia Commonwealth University

Structure-Activity Relationships of 'Bath Salt' Constituents

Michael Gatch - University of North Texas Health Science Center

In Vivo Pharmacology of Novel Synthetic Cathinones

Jacques Nguyen - Scripps Research Institute

Locomotor Stimulant and Rewarding Effects of Inhaled 'Bath Salts'

Annette Fleckenstein - University of Utah

Neurochemical Deficits Induced by Synthetic Cathinones

Gregory Collins - University of Texas Health Science Center at San Antonio

Reinforcing Effects of Novel Synthetic Cathinones and Their Mixtures

Samantha McClenahan - University of Arkansas for Medical Sciences

Development and Preclinical Testing of a Vaccine for 3,4-Methylenedioxypyrovalerone ((R,S)-MDPV) Substance Use Disorders